BFK — Pharmesis International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Pharmesis International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	15.2	14	19.7	9.48	4.6
Net Total Accounts Receivable
Net Total Receivables	12.7	14.2	12.9	8.31	37.7
Total Inventory
Prepaid Expenses
Total Current Assets	37	37.1	44.2	33.3	56.5
Net Property, Plant And Equipment	51.8	53.1	51.3	50.2	56.6
Net Goodwill
Long Term Investments
Other Long Term Assets
Total Assets	91.3	92.7	97.9	85.9	116
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32.4	30.8	39.6	30.6	53.6
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	35	35.2	44	34.8	54.3
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	56.3	57.5	53.9	51.1	61.6
Total Liabilities & Shareholders' Equity	91.3	92.7	97.9	85.9	116
Total Common Shares Outstanding